Modulation of Ia afferent activity through the fusimotor system decreases low-frequency force variability (1-5 Hz) while it increases physiological tremor (5-12 Hz). by Akira Nagamori (4743981)

Decreased numbers of motor neurons in Tc1 and Dp(16)1Yey mice. by Sheona Watson-Scales (586942)

Deletion of <i>sagA</i> alone results in a decrease in nasopharyngeal infection. by Blake A. Shannon (14197601)

TBEV-induced translational arrest results in the decreased protein levels of GAPDH, HPRT1, and viperin. by Martin Selinger (3195987)

Cycloheximide (CHX) treatment decreases production of rRNA transcripts by POLR1 and POLR3. by Martin Selinger (3195987)

“…<p>(A) DAOY cells were treated with CHX (100 μg/ml) for either 6 or 14 hours; for metabolic RNA labelling, 5-EU was added 2 hours before the sample collection. …”

Estradiol decreased vanillin-induced responses in the ORNs of p5 mice. by Ninthujah Kanageswaran (683924)

“…<p>(A) Representative responses to 100 μM vanillin from Olfr73 positive ORNs in tissue slices were obtained from patch-clamp recordings set to a voltage-clamp configuration (V_h = -56 mV). …”

Decreased brain-derived neurotrophic factor plasma levels in psoriasis patients by A.R. Brunoni (5694239)

TG6-44 treatment leads to decrease in A/X31-induced cell death in THP-1 cells. by Juan A. De La Cruz (11154187)

CDK5 knockdown increases TP53 and p27^Kip1 protein half-lives, increases nuclear localization of the two proteins, decreases p27^Kip1 p-T187 phosphorylation and induces p21^Cip1 in a TP53-dependent manner. by Shu Zhang (22238)

“…Cytoplasmic (CE) and nuclear (NE) extracts were analyzed by immunoblotting. (<b>C</b>) CDK5 siRNA decreased the phosphorylation of p27Kip1 at T187. …”

Normalized whole brain volume change over 5 years using an SPM pipeline. by Renxin Chu (5169857)

Fig 5 - by Mestewat Simeon (19233200)

The G215S mutation decreases packaging of N and growth in primary differentiated human bronchial cells. by Hannah C. Kubinski (21213168)

Simulated response to Ach at activated NALCN channels and decreased phosphodiesterase (PDE) activity in low glucose. by Leonid E. Fridlyand (2636968)

“…<p>(A) PM potentials (V_p); (B) [Ca²⁺]_c and [Ca²⁺]_ER; (C) Cytoplasmic cAMP and IP₃ concentrations. …”

MCP-1-deficiency decreased CD11c-expressing cells via impairing the production of ROS and decreased activation of PLCγ2, Akt, and ERK upon M-CSF stimulation in BMM. by Woon-Ki Kim (447798)

“…<p>BMMs from WT (open bar) and MCP-1-KO mice (oblique-lined bar) were incubated in the presence of M-CSF (30 ng/ml) with U73122 (10 µM), Akt inhibitor IV (0.3 µM), PD098059 (5 µM), DPI (50 nM), NAC (3 mM), or H₂O₂ (300 µM) for 4 d (A). *, <i>P</i><0.05; ***, <i>P</i><0.001 compared with vehicle-treated WT cells. …”

CaA decreases the CSCs-like properties of malignant HaCaT cells. by Ye Yang (297214)

Nivalenol (NIV) decreases chondrocyte viability in a dose and duration-dependent manner. by Siyuan Li (178640)

Decreased autoantibody production in IRF5-deficient MRL/lpr mice. by Kei Yasuda (606333)

Treatment with HBOT or PFD decreased IL-17A expression in the AD lesions. by Hyung-Ran Kim (532404)

Knockdown of p65 in A549 cells results in a decreased infection rate. by Janine J. Wilden (8849948)

TPI demalonylation at K56 decreases PPP flux in CDCP1+ CSCs and is indispensable for postchemotherapeutic recurrence. by WenChao Gao (7321640)